Literature DB >> 12556378

Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells.

Yuichi Kaji1, Shiro Amano, Tomohiko Usui, Tetsuro Oshika, Kenji Yamashiro, Susumu Ishida, Kaori Suzuki, Sumiyoshi Tanaka, Anthony P Adamis, Ryoji Nagai, Seiko Horiuchi.   

Abstract

PURPOSE: The corneal endothelium is a target of the aging process. This study was undertaken to reveal the relationship between corneal endothelial cell (CEC) death and the accumulation of advanced glycation end products (AGEs), by investigating the possible mechanism of accumulation of AGE in CECs and its effects on CEC death.
METHODS: First, the in vivo expression of the receptor was investigated for AGE (RAGE) and galectin-3, both receptors for AGE, at both the mRNA and protein levels. Second, AGEs were added to the culture media of the cultured CECs, and the uptake of AGEs, the generation of reactive oxygen species, and the induction of apoptosis were investigated.
RESULTS: Immunohistochemistry and RT-PCR demonstrated that both RAGE and galectin-3 were expressed in bovine CECs. After administration of AGE-modified bovine serum albumin to the culture medium, uptake of AGE was observed in the cytoplasm of the cultured bovine CECs. In addition, with increasing concentration of AGEs, the generation of reactive oxygen and the number of apoptotic cells also increased.
CONCLUSIONS: These results show that the accumulation of AGEs in CECs induced apoptosis, in part, by increasing cellular oxidative stress. The accumulation of AGEs in the CECs of elderly patients may be involved in the loss of CECs during the aging process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12556378     DOI: 10.1167/iovs.02-0268

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  25 in total

Review 1.  Biology of corneal endothelial cells in vivo and in vitro.

Authors:  Shiro Amano; Yuichi Kaji; Tatsuya Mimura
Journal:  Jpn J Ophthalmol       Date:  2010-06-25       Impact factor: 2.447

2.  Prevention of diabetic keratopathy.

Authors:  Y Kaji
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

3.  Immunohistochemical localization of advanced glycation end products in pinguecula.

Authors:  Yuichi Kaji; Tetsuro Oshika; Shiro Amano; Fumiki Okamoto; Wakako Koito; Seikoh Horiuchi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-21       Impact factor: 3.117

4.  Tanshinone IIA protects against methylglyoxal-induced injury in human brain microvascular endothelial cells.

Authors:  Wen-Jing Zhou; Qi-Feng Gui; Yue Wu; Yun-Mei Yang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 5.  Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology.

Authors:  Min K Song; Basil D Roufogalis; Tom H W Huang
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

Review 6.  Ocular complications of diabetes mellitus.

Authors:  Nihat Sayin; Necip Kara; Gökhan Pekel
Journal:  World J Diabetes       Date:  2015-02-15

7.  AGEs Promote Oxidative Stress and Induce Apoptosis in Retinal Pigmented Epithelium Cells RAGE-dependently.

Authors:  Xin-Ling Wang; Tao Yu; Qi-Chang Yan; Wei Wang; Nan Meng; Xue-Jiao Li; Ya-Hong Luo
Journal:  J Mol Neurosci       Date:  2015-02-15       Impact factor: 3.444

8.  Galectin-3: a potential target for cancer prevention.

Authors:  Hafiz Ahmed; Prasun Guha; Engin Kaptan; Gargi Bandyopadhyaya
Journal:  Trends Carbohydr Res       Date:  2011

9.  KIOM-79 Prevents Lens Epithelial Cell Apoptosis and Lens Opacification in Zucker Diabetic Fatty Rats.

Authors:  Junghyun Kim; Chan-Sik Kim; Eunjin Sohn; Hyojun Kim; Il-Ha Jeong; Jin Sook Kim
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-07       Impact factor: 2.629

Review 10.  Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation.

Authors:  Shi Fang Yan; Shi Du Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Ann Med       Date:  2009       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.